PYR101 Episode 7
Open Access and ACS AuthorChoice
“These sessions are especially helpful for those students and researchers who are new to the publishing of scientific informa...Frederick Malan, Graduate StudentUniversity of Johannesburg
Publishing Your Research 101
Episode 7 – Open Access and ACS AuthorChoice
About the Episode
The seventh episode focuses on open access for journal articles and the ACS AuthorChoice program featuring Larry Marnett, the Editor-in-Chief of Chemical Research in Toxicology. Dr. Marnett was an early proponent among ACS editors for open access, a publishing model in which an article is available to all users without regard to subscription. The first fully open access article published in any ACS journal was one of his 2006 articles. There are various economic models across scientific publishing for enabling open access; the ACS AuthorChoice program is the option available within ACS Publications. The program allows an author to pay an open access fee (a basic fee with discounts for subscribing institutions and ACS members) to make his/her article openly available upon publication. This allows the author to fulfill funding agency requirements or to make a personal choice on open access. Marnett discusses open access, why he selects the ACS AuthorChoice option when publishing in ACS journals, and notes that selecting the AuthorChoice option has no impact on whether an article will be accepted for publication.
- Open Access Publication: One Editor’s Opinion, Lawrence J. Marnett, Chem. Res. Toxicol. 2005, 18 (5), 787-789
- The Advantages of Open Access
- ACS AuthorChoice policy
- Marnett’s first ACS AuthorChoice article, Characterization of the Amino Acid Adducts of the Enedial Derivative of Teucrin A
About The Author
Lawrence J. Marnett
Professor of Cancer Research, Vanderbilt University School of Medicine
Lawrence J. Marnett is the founding and current Editor-in-Chief of Chemical Research in Toxicology. He is the Mary Geddes Stahlman Professor of Cancer Research, Vanderbilt University School of Medicine, and Director of the Vanderbilt Institute of Chemical Biology. He received his B.S. degree from Rockhurst College and his Ph.D. in chemistry from Duke University. His research interests include enzyme cyclooxygenase-2 in cancer and inflammation as well as on the contribution of normal metabolism to the generation of DNA damage and mutation. He is author of more than 380 research publications and 10 patents. Learn more
WHY ACS ON CAMPUS IS FOR YOU
Leaders in the field
Heather L. Tierney, Ph.D.
Managing Editor, ACS Nano & Nano Letters
Heather received her Bachelor's degree in Chemistry from Assumption College in Worcester, MA. She then proceeded to complete a Ph. D. in Chemistry at Tufts University, where she used a combination of scanning tunneling microscopy (STM) and density functional theory (DFT) to study the surface chemistry of a variety of systems including bimetallic alloys, molecular self-assembly, and single-molecule rotors. Heather joined the Publications Division of the American Chemical Society in 2010 as the Managing Editor for ACS Nano and Nano Letters.